
Journal of the Brazilian Chemical Society p. 998 - 1006 (2016)
Update date:2022-08-17
Topics:
Abro, Rashid
Gao, Shurong
Chen, Xiaochun
Yu, Guangren
Abdeltawab Salem, Ahmed A.
Al-Deyabb
In this work, desulfurization of real fluidized catalytic cracking (FCC) gasoline was investigated in dual steps; first in oxidative desulfurization (ODS) using imidazolium and pyrrolidonium based Br?nsted acidic ionic liquids (ILs) as solvent and catalyst and hydrogen peroxide as oxidant. In second step, extractive desulfurization took place using organic solvents of furfural, furfural alcohol and ethylene glycol. Variety of factors such as temperature, time, mass ratio of oil/ILs and regeneration and recycling of ILs, multiple-step desulfurization of ILs and organic solvents and solvent/oil ratio were also investigated. The S-content was significantly decreased to ca. 18 ppm from initial S-content of 260 ppm with a total S-removal of ca. 95percent in one-step ODS using pyrrolidonium based ILs coupled with five-step extraction desulfurization (EDS) using furfural alcohol as extractant. This work shows that oxidative desulfurization using ionic liquids coupled with extractive desulfurization using organic solvents is a potential method to produce clean gasoline.
Shanghai Massive Chemical Technology Co., Ltd.
website:http://www.massivechem.com/
Contact:+86 21 34943721
Address:Room 435, 4th floor, Building 9, No. 2568 Gudai Road,Minhang District, Shanghai,
Yancheng Creator Chemical Co., Ltd
Contact:0086-515-88710008 88710068 88710858 88710868
Address:No.21 Renming Road, Longgang Town, Yandu County,Yancheng City
Chengdu Green Young Biopharmaceutical INC
Contact:+86-28-85337952
Address:1-B-26,Tianhe Industry Park, No.1480 of Tianfu Road,Chengdu,P.R.China,610000
Hangzhou Dingyan Chem Co., Ltd
website:http://www.dingyanchem.com
Contact:86-571-87157530
Address:RM.1118,NO.1 Building, Baiyun Tower,Jianggan Area, Hangzhou city, China,310004
website:http://www.antimex.com
Contact:0086-21-50563169
Address:Room1027,No.Jinyu Road,Pudong
Doi:10.1039/b110368g
(2002)Doi:10.1016/0040-4020(96)00642-4
(1996)Doi:10.1246/cl.1995.665
(1995)Doi:10.1021/ja01120a525
(1953)Doi:10.1139/v97-108
(1997)Doi:10.3797/scipharm.2007.75.9
(2007)